Accelerating Peptide DiscoveryYour solutions for peptide evolution
Powered by our DARWIN AI platform, smart solutions are at the core of all that we do at NuvoBio. Our main goal is to find smart ways of using technology that will help accelerate drug development. By learning how proteins naturally interact with each other, our DARWIN AI platform accelerates the pace of peptide discovery by providing libraries of peptides with therapeutic potential.
Who WE Are
NuvoBio is a bio-medical technology company dedicated to expediting the development of peptide therapeutics. Using our novel Darwin AI technology platform to design highly specific binding peptides, we are developing intellectual property and advancing research and development in the areas of new synthetic drugs, immunotherapies and other unique applications.
GET IN TOUCH
If you have questions or would like to discuss our technology, please contact us.